Literature DB >> 22516003

Excess mortality among the elderly in 12 European countries, February and March 2012.

A Mazick1, B Gergonne, J Nielsen, F Wuillaume, M J Virtanen, A Fouillet, H Uphoff, T Sideroglou, A Paldy, A Oza, B Nunes, V M Flores-Segovia, C Junker, S A McDonald, H K Green, R Pebody, K Mølbak.   

Abstract

In February and March 2012, excess deaths among the elderly have been observed in 12 European countries that carry out weekly monitoring of all-cause mortality. These preliminary data indicate that the impact of influenza in Europe differs from the recent pandemic and post-pandemic seasons. The current excess mortality among the elderly may be related to the return of influenza A(H3N2) virus, potentially with added effects of a cold snap.

Entities:  

Mesh：

Year:  2012        PMID： 22516003

Source DB:  PubMed          Journal:  Euro Surveill        ISSN： 1025-496X


  18 in total

1.  Mortality in Spain in the Context of the Economic Crisis and Austerity Policies.

Authors:  Enrique Regidor; Alberto Mateo; Gregorio Barrio; Luis de la Fuente
Journal:  Am J Public Health       Date:  2019-05-16       Impact factor: 9.308

2.  Surveillance of influenza viruses in the post-pandemic era (2010-2012) in Northern Italy.

Authors:  Elena Pariani; Antonella Amendola; Alberto Ranghiero; Giovanni Anselmi; Alessandro Zanetti
Journal:  Hum Vaccin Immunother       Date:  2013-01-09       Impact factor: 3.452

3.  The COVID-19 Disease Burden in Germany in 2020—Years of Life Lost to Death and Disease Over the Course of the Pandemic.

Authors:  Alexander Rommel; Elena von der Lippe; Dietrich Plass; Thomas Ziese; Michaela Diercke; Matthias An der Heiden; Sebastian Haller; Annelene Wengler
Journal:  Dtsch Arztebl Int       Date:  2021-03-05       Impact factor: 5.594

4.  Why are older adults and individuals with underlying chronic diseases in Germany not vaccinated against flu? A population-based study.

Authors:  Birte Bödeker; Cornelius Remschmidt; Patrick Schmich; Ole Wichmann
Journal:  BMC Public Health       Date:  2015-07-07       Impact factor: 3.295

5.  Public health and economic impact of seasonal influenza vaccination with quadrivalent influenza vaccines compared to trivalent influenza vaccines in Europe.

Authors:  Mathieu Uhart; Hélène Bricout; Emilie Clay; Nathalie Largeron
Journal:  Hum Vaccin Immunother       Date:  2016-05-11       Impact factor: 3.452

6.  Excess all-cause and influenza-attributable mortality in Europe, December 2016 to February 2017.

Authors:  Lasse S Vestergaard; Jens Nielsen; Tyra G Krause; Laura Espenhain; Katrien Tersago; Natalia Bustos Sierra; Gleb Denissov; Kaire Innos; Mikko J Virtanen; Anne Fouillet; Theodore Lytras; Anna Paldy; Janos Bobvos; Lisa Domegan; Joan O'Donnell; Matteo Scortichini; Annamaria de Martino; Kathleen England; Neville Calleja; Liselotte van Asten; Anne C Teirlinck; Ragnhild Tønnessen; Richard A White; Susana P Silva; Ana P Rodrigues; Amparo Larrauri; Inmaculada Leon; Ahmed Farah; Christoph Junker; Mary Sinnathamby; Richard G Pebody; Arlene Reynolds; Jennifer Bishop; Diane Gross; Cornelia Adlhoch; Pasi Penttinen; Kåre Mølbak
Journal:  Euro Surveill       Date:  2017-04-06

7.  Influenza vaccine effectiveness among high-risk groups: A systematic literature review and meta-analysis of case-control and cohort studies.

Authors:  Vincenzo Restivo; Claudio Costantino; Stefania Bono; Marialuisa Maniglia; Valentina Marchese; Gianmarco Ventura; Alessandra Casuccio; Fabio Tramuto; Francesco Vitale
Journal:  Hum Vaccin Immunother       Date:  2017-06-16       Impact factor: 3.452

8.  Age distribution of influenza like illness cases during post-pandemic A(H3N2): comparison with the twelve previous seasons, in France.

Authors:  Clément Turbelin; Cécile Souty; Camille Pelat; Thomas Hanslik; Marianne Sarazin; Thierry Blanchon; Alessandra Falchi
Journal:  PLoS One       Date:  2013-06-05       Impact factor: 3.240

9.  Enhanced Estimates of the Influenza Vaccination Effect in Preventing Mortality: A Prospective Cohort Study.

Authors:  Jesús Castilla; Marcela Guevara; Iván Martínez-Baz; Carmen Ezpeleta; Josu Delfrade; Fátima Irisarri; Conchi Moreno-Iribas
Journal:  Medicine (Baltimore)       Date:  2015-07       Impact factor: 1.889

Review 10.  Influenza vaccination in high-risk groups: a revision of existing guidelines and rationale for an evidence-based preventive strategy.

Authors:  C Costantino; F Vitale
Journal:  J Prev Med Hyg       Date:  2016
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.